Cargando…

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis

At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis included off-label immunosuppressants and corticosteroids. Immunosuppressant therapy is associated with a substantial risk of side-effects, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, April W., Huang, Ahong, Wang, Li, Miao, Raymond, Patel, Miraj Y., Gadkari, Abhijit, Mallya, Usha G., Chao, Jingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347241/ https://www.ncbi.nlm.nih.gov/pubmed/30682042 http://dx.doi.org/10.1371/journal.pone.0210517

Ejemplares similares

Effects of variations in access to care for children with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2020)

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
por: Eichenfield, Lawrence F., et al.
Publicado: (2022)

Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
por: Simpson, Eric, et al.
Publicado: (2019)

The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis
por: Wu, Jashin J., et al.
Publicado: (2021)

Patient Journey in Atopic Dermatitis: The Real-World Scenario
por: Carrascosa, Jose Manuel, et al.
Publicado: (2021)

Discordance Between Physician- and Patient-Reported Disease Severity in Adults with Atopic Dermatitis: A US Cross-Sectional Survey
por: Wei, Wenhui, et al.
Publicado: (2017)

Real-world treatment patterns for atopic dermatitis in South Korea
por: Lee, Ji Hyun, et al.
Publicado: (2022)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
por: Lee, Dong Hun, et al.
Publicado: (2022)

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
por: Kamata, Masahiro, et al.
Publicado: (2021)

Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
por: Kuznik, Andreas, et al.
Publicado: (2017)

Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry
por: LARSEN, Henrik H. P., et al.
Publicado: (2022)

US health care utilization and costs in adult patients with atopic dermatitis by disease severity
por: Wang, Xin, et al.
Publicado: (2022)

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases
por: Shrestha, Sulena, et al.
Publicado: (2017)

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
por: Yosipovitch, Gil, et al.
Publicado: (2021)

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment
por: Bakker, Daphne S., et al.
Publicado: (2019)

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)
por: Bagel, Jerry, et al.
Publicado: (2022)

Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey
por: Arima, Kazuhiko, et al.
Publicado: (2018)

Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
por: Zhou, Bingjing, et al.
Publicado: (2022)

Process utilities for topical treatment in atopic dermatitis
por: Retzler, Jenny, et al.
Publicado: (2019)

Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
por: Owji, Shayan, et al.
Publicado: (2022)

Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis
por: Wei, Wenhui, et al.
Publicado: (2017)

Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey
por: AUGUSTIN, Matthias, et al.
Publicado: (2022)

Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2019)

Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case Report
por: Moennig, Eva, et al.
Publicado: (2022)

Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data Analysis
por: Leshem, Yael A., et al.
Publicado: (2022)

Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults
por: Silverberg, J.I., et al.
Publicado: (2019)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010
por: Rehal, Balvinder, et al.
Publicado: (2011)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience
por: Stingeni, L., et al.
Publicado: (2022)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010
por: Rehal, Balvinder, et al.
Publicado: (2011)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
por: DELEURAN, Mette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2oqlhjvhcmji3h8fm07c46i3p